Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes

Journal of Diabetes and its Complications

Volumn 23, Issue 2, 2009, Pages 130-136

  Haidara, Mohamed A ^a   Mikhailidis, Dimitri P ^b,c   Rateb, Moshira A ^a   Ahmed, Zeinab A ^a   Yassin, Hanaa Z ^a   Ibrahim, Ibrahim M ^a   Rashed, Laila A ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antioxidants; Diabetes; Oxidative stress; Renal function; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CREATININE; CYCLIC GMP; GLUCOSE; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; MALONALDEHYDE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; KIDNEY FUNCTION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; BLOOD GLUCOSE; CREATININE; CYCLIC GMP; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE TRANSFERASE; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; MALE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; UREA; VITAMIN E;

EID: 59849084406     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.02.011     Document Type: Article

References (49)

1. Angula J., Cuevas P., Fernandez A., Gabancho S., Allona A., Martin- Morales A., and Moncada I. Activation and potentiation of the NO/cGMP pathway by NG- hydroxyl-l-arginine in rabbit corpus cavernosum under normoxic and hypoxic condition and aging. Br J Pharmacol 138 (2003) 63-70
2. Athyros V.G., Elisaf M., Papageorgiou A.A., Symeonidis A.N., Pehlivanidis A.N., Bouloukos V.I., Milionis H.J., Mikhailidis D.P., and GREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. American Journal of Kidney Diseases 43 4 (2004) 589-599
3. Athyros V.G., Mikhailidis D.P., Papageorgiou A.A., Symeonidis A.N., Pehlivanidis A.N., Bouloukos V.I., and Elisaf M. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. Journal of Clinical Pathology 57 7 (2004) 728-734
4. Athyros V.G., Mikhailidis D.P., Liberopoulos E.N., Kakafika A.I., Karagiannis A., Papageorgiou A.A., Tziomalos K., Ganotakis E.S., and Elisaf M. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrology, Dialysis, Transplantation 22 1 (2007) 118-127
5. Bretaudiere J.P., Thieu-Phung H., and Baily H. Direct enzymatic determination of urea in the plasma and urine with a centrifugal analyzer. Clinical Chemistry 22 (1976) 1614-1617
6. Caramori M.L., Kim Y., Huang C., Fish A.J., Rich S.S., Miller M.E., Russell G., and Mauer M. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51 (2002) 506-513
7. Cardillo C., Nambi S.S., and Kilcoyne C.M. Insulin stimulates both endothelium and nitric oxide activity in the human forearm. Circulation 100 (1999) 820-825
8. Collins R., Armitage J., Parish S., Sleigh P., Peto R., and Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
9. Devaraj S., and Jialal I. The effect of a-tocopherol supplementation on monocyte function. The Journal of Clinical Investigation 98 (1996) 756-763
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 329 (1993) 977-986
11. Draper H.H., and Hadley M. Assessment of malondialdehyde method. Enzymology 186 (1991) 421-443
12. Esqueda D.M.E., Hernández V.A., and Morales M.F. Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus. Renal Failure 27 1 (2005) 115-122
13. Flohe R., and Kelly F. The European perspective of Vit. E. The American Journal of Clinical Nutrition 76 (2002) 703-716
14. Gisinger C., Jeremy J., Speiser P., Mikhailidis D., Dandona P., and Schernthaner G. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes 37 (1988) 1260-1264
15. Ha H., and Kim K.H. Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase C. Diabetes Research and Clinical Practice 45 (1999) 147-151
16. Haidara M., Desoky A., Khlousy H., and Sebaee H. The mechanisms underlying the development of hypertension in STZ induced diabetic rats. Progress in Medical Research 2 (2004) 1-18
17. Haidara M., Khloussy H., Ammar H., and Aal Kassem L.A. Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes. Medical Science Monitor 10 2 (2004) BR41-BR46
18. Haidara M., Yassin H., Rateb M., Ammar H., and Zorkani M. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Current Vascular Pharmacology 4 (2006) 215-227
19. Horton J.W., White D.J., Maass D.L., Hybki D.P., Haudek S., and Giroir B. Antioxidant vitamin therapy alters burn trauma mediated cardiac NF-kB activation and cardiomyocyte cytokine secretion. Trauma 50 (2001) 397-406
20. Hsu C., Bates D., Kuperman G., and Curhan G. Diabetes, hemoglobin A (1c) cholesterol and the risk of moderate chronic renal insufficiency in an ambulatory population. American Journal of Kidney Diseases 36 (2001) 272-281
21. Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., et al. Amelioration of vascular dysfunction in diabetic rats by an oral protein kinase beta inhibitor. Science 272 (1996) 728-731
22. Ishii N., Patel K.P., Lane P.H., Taylor T., Bian K., Murad F., Pollock J.S., and Carmines P.K. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. Journal of the American Society of Nephrology 12 (2001) 1630-1639
23. Iwashina M., Shichiri M., Marumo F., and Hirata Y. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 98 (1998) 1212-1218
24. Kessler P., Bauersachs J., Busse R., and Schini-Kerth V.B. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in pro-inflammatory mediator-induced blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 17 (1997) 1746-1755
25. Knoll K., Pietrusz J., and Liang M. Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiological Genomics 21 (2005) 222-229
26. Koya D., Lee I., Ishii H., Kanoh H., and King G. Prevention of glomerular dysfunction in diabetic rats by treatment with d-a-tocopherol. Journal of the American Society for Nephrology 8 (1997) 426-435
27. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., and Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. American Society of Nephrology 14 (2003) S250-S253
28. Lee H.B., Yu M.R., Yang Y., Jiang Z., and Ha H. Reactive oxygen species-regulated signalling pathways in diabetic nephropathy. Journal of the American Society for Nephrology 14 (2003) S241-S245
29. Marletta M.A. Nitric oxide: biosynthesis and biological significance. Trends in Pharmacological Sciences 158 (1989) 348-352
30. Mauer M., Fioretto P., Woredekal Y., and Friedman E.A. Diabetic nephropathy. In: Schrier R.W. (Ed). Diseases of the kidney. (7th ed.) (2001), Lippincott Williams & Wilkins, Philadelphia
31. Mauer M., and Drummond K. The International Diabetic Nephropathy Study Group: The early natural history of nephropathy in type 1 diabetes: 1. Study design and baseline characteristics of the study participants. Diabetes 51 (2002) 1572-1579
32. Michel T., and Feron O. Nitric oxide synthases: Which, where, how, and why?. The Journal of Clinical Investigation 100 (1997) 2146-2152
33. Moncada S., and Higgs E.A. The l-arginine-nitric oxide pathway. The New England Journal of Medicine 329 (1993) 2002-2012
34. Mustata G., Rosca M., Biemel K., Reihl O., Smith M., Viswanathan A., Strauch C., Du Y., Tang J., Kern T., Lederer M., Brownlee M., Weiss M., and Monnier V. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes 54 (2005) 517-526
35. Nathan C. Inducible nitric oxide synthase: what difference does it make?. The Journal of Clinical Investigation 100 (1997) 2417-2423
36. Noh H., Ha H., Yu M.R., Kang S.W., Choi K.H., Han D.S., and Lee H.Y. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production. Nephron 90 (2002) 78-85
37. Pagalia D.E., and Valentine W.N. Studies on quantitative and qualitative characterization of erythrocyte GPx. The Journal of Laboratory and Clinical Medicine 70 (1967) 158
38. Powell L., Warpeha K., Xu W., Walker B., and Trimble E. High glucose decreases intracellular glutathione concentrations and upregulates inducible nitric oxide synthase gene expression in intestinal epithelial cells. Journal of Molecular Endocrinology 33 (2004) 797-803
39. Ritz E., Keller C., Bergis K., and Strojek K. Pathogenesis and course of renal disease in IDDM/NIDDM: differences and similarities. American Journal of Hypertension 10 (1997) 202S-207S
40. Sen C.K., and Packer L.T. Homeostasis and supplements in physical exercise. The American Journal of Clinical Nutrition 72 (2000) 653-695
41. Shimabukuro M., Ohneda M., Lee Y., and Unger R. Role of nitric oxide in obesity-induced b cell disease. The Journal of Clinical Investigation 100 (1997) 290-295
42. Sun L., Halaihel N., Zhang W., Rogers T., and Levi M. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. The Journal of Biological Chemistry 277 (2002) 18919-18927
43. Tietz N.W. Fundamentals of clinical chemistry. 3rd edition (1987), W.B. Saunder Company 68
44. Trinder P. Enzymatic determination of blood glucose. Annals of Clinical Biochemistry 6 (1969) 24-26
45. United States Renal Data System (USRDS). 2000 Annual data report (2000), National Institutes of Health, Bethesda, MD
46. Wheatcrot S.B., Kearney M.T., Shah A.M., Grieve D.J., Williams I.L., Miell J.P., and Crossey P.A. Endothelial function and blood pressure homeostasis in mice over expressing IGF binding protein-1. Diabetes 52 (2003) 2075-2082
47. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. The Journal of Biological Chemistry 273 (1998) 25804-25808
48. Xu R., Morales J.A., Muniyappa R., Skafar D.F., Ram J.L., and Sowers J.R. IL-1-induced nitric oxide production in rat aortic endothelial cells: Inhibition by estradiol in normal and high glucose cultures. Life Sciences 64 (1999) 2451-2462
49. Yechoor V.K., Patti M.E., Saccone R., and Kahn C.R. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 10587-10592